These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31427139)

  • 1. Comparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosis.
    Lewis RE; Wurster S; Beyda ND; Albert ND; Kontoyiannis DP
    Diagn Microbiol Infect Dis; 2019 Nov; 95(3):114861. PubMed ID: 31427139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of isavuconazole versus opportunistic filamentous fungal pathogens from the SENTRY Antifungal Surveillance Program, 2017-2018.
    Messer SA; Carvalhaes CG; Castanheira M; Pfaller MA
    Diagn Microbiol Infect Dis; 2020 May; 97(1):115007. PubMed ID: 32081523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of isavuconazole against Trichosporon, Rhodotorula, Geotrichum, Saccharomyces and Pichia species.
    Thompson GR; Wiederhold NP; Sutton DA; Fothergill A; Patterson TF
    J Antimicrob Chemother; 2009 Jul; 64(1):79-83. PubMed ID: 19406849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal susceptibilities of opportunistic filamentous fungal pathogens from the Asia and Western Pacific Region: data from the SENTRY Antifungal Surveillance Program (2011-2019).
    Pfaller MA; Carvalhaes CG; Rhomberg P; Messer SA; Castanheira M
    J Antibiot (Tokyo); 2021 Aug; 74(8):519-527. PubMed ID: 34188199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values.
    Pfaller MA; Rhomberg PR; Messer SA; Jones RN; Castanheira M
    Diagn Microbiol Infect Dis; 2015 Aug; 82(4):303-13. PubMed ID: 25986029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activities of isavuconazole against opportunistic filamentous and dimorphic fungi.
    González GM
    Med Mycol; 2009 Feb; 47(1):71-6. PubMed ID: 19101837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Activity of Isavuconazole and Comparators against Clinical Isolates of the Mucorales Order.
    Arendrup MC; Jensen RH; Meletiadis J
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7735-42. PubMed ID: 26438494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
    Fera MT; La Camera E; De Sarro A
    Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antifungal activity of posaconazole against various pathogenic fungi.
    Uchida K; Yokota N; Yamaguchi H
    Int J Antimicrob Agents; 2001 Aug; 18(2):167-72. PubMed ID: 11516940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isavuconazole: A new broad-spectrum azole. Part 1: In vitro activity.
    Denis J; Ledoux MP; Nivoix Y; Herbrecht R
    J Mycol Med; 2018 Mar; 28(1):8-14. PubMed ID: 29534853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yeast-like filamentous fungi: Molecular identification and in vitro susceptibility study.
    Esposto MC; Prigitano A; Lo Cascio G; Ossi C; Grancini A; Cavanna C; Lallitto F; Tejada M; Bandettini R; Mularoni A; Tortorano AM
    Med Mycol; 2019 Oct; 57(7):909-913. PubMed ID: 30521007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activities of new and established triazoles against opportunistic filamentous and dimorphic fungi.
    González GM; Fothergill AW; Sutton DA; Rinaldi MG; Loebenberg D
    Med Mycol; 2005 May; 43(3):281-4. PubMed ID: 16010855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the EUCAST and CLSI Broth Microdilution Methods for Testing Isavuconazole, Posaconazole, and Amphotericin B against Molecularly Identified Mucorales Species.
    Chowdhary A; Singh PK; Kathuria S; Hagen F; Meis JF
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7882-7. PubMed ID: 26438489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
    Espinel-Ingroff A
    J Clin Microbiol; 2001 Mar; 39(3):954-8. PubMed ID: 11230410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi.
    Marco F; Pfaller MA; Messer SA; Jones RN
    Med Mycol; 1998 Dec; 36(6):433-6. PubMed ID: 10206756
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Pfaller MA; Rhomberg PR; Wiederhold NP; Gibas C; Sanders C; Fan H; Mele J; Kovanda LL; Castanheira M
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30061288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens.
    Biswas C; Sorrell TC; Djordjevic JT; Zuo X; Jolliffe KA; Chen SC
    J Antimicrob Chemother; 2013 Dec; 68(12):2842-6. PubMed ID: 23861311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs.
    Drogari-Apiranthitou M; Mantopoulou FD; Skiada A; Kanioura L; Grammatikou M; Vrioni G; Mitroussia-Ziouva A; Tsakris A; Petrikkos G
    J Antimicrob Chemother; 2012 Aug; 67(8):1937-40. PubMed ID: 22535624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posaconazole: a broad-spectrum triazole antifungal.
    Torres HA; Hachem RY; Chemaly RF; Kontoyiannis DP; Raad II
    Lancet Infect Dis; 2005 Dec; 5(12):775-85. PubMed ID: 16310149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.
    Espinel-Ingroff A
    Rev Iberoam Micol; 2003 Dec; 20(4):121-36. PubMed ID: 15456349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.